Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.79%) $83.19
Gas
(-1.16%) $1.619
Gold
(-0.44%) $2 336.80
Silver
(0.93%) $27.51
Platinum
(0.60%) $927.60
USD/EUR
(-0.16%) $0.933
USD/NOK
(-0.14%) $11.01
USD/GBP
(-0.24%) $0.798
USD/RUB
(0.00%) $92.17

Sanntidsoppdatering for Innovent Biologics Inc [1801.HK]

Børs: HKSE Industri: Pharmaceuticals, Biotechnology & Life Sciences
Sist oppdatert29 apr 2024 @ 05:14
25% discount on Stockinvest.us - Use code: Podcast

3.19% HKD 40.40

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 05:14):

Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases...

Stats
Dagens volum 3.18M
Gjennomsnittsvolum 9.41M
Markedsverdi 65.56B
EPS HKD0 ( 2024-03-25 )
Neste inntjeningsdato ( HKD0 ) 2024-06-20
Last Dividend HKD0 ( N/A )
Next Dividend HKD0 ( N/A )
P/E -56.90
ATR14 HKD0.0520 (0.13%)

Volum Korrelasjon

Lang: -0.10 (neutral)
Kort: 0.30 (neutral)
Signal:(61.003) Neutral

Innovent Biologics Inc Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Innovent Biologics Inc Korrelasjon - Valuta/Råvare

The country flag 0.66
( moderate )
The country flag 0.61
( weak )
The country flag 0.00
( neutral )
The country flag 0.68
( moderate )
The country flag 0.06
( neutral )
The country flag -0.77
( moderate negative )

Innovent Biologics Inc Økonomi

Annual 2023
Omsetning: HKD6.21B
Bruttogevinst: HKD4.40B (70.89 %)
EPS: HKD-0.660
FY 2023
Omsetning: HKD6.21B
Bruttogevinst: HKD4.40B (70.89 %)
EPS: HKD-0.660
FY 2022
Omsetning: HKD4.56B
Bruttogevinst: HKD3.63B (79.57 %)
EPS: HKD-1.460
FY 2021
Omsetning: HKD4.27B
Bruttogevinst: HKD3.70B (86.58 %)
EPS: HKD-2.31

Financial Reports:

No articles found.

Innovent Biologics Inc

Innovent Biologics, Inc. operates as a biopharmaceutical company in China. The company operates a platform for the discovery, development, and manufacture of antibody drug candidates in the fields of oncology, ophthalmology, immunology, and metabolic diseases. Its principal drug candidate is Tyvyt (sintilimab), an anti-PD-1 monoclonal antibody for the treatment of cancer, Hodgkin's lymphoma, and esophageal carcinoma. The company also offers Byvasda for the treatment of several malignant tumors; Halpryza for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and Wegener's granulomatosis; Pemazyre for the treatment of adults with locally advanced or metastatic cholangiocarcinoma; Olverembatinib for the treatment of adult patients with tyrosine kinase inhibitor; and Cyramza to treat four different types of cancers. In addition, it engages in the development of IBI-301, a rituximab biosimilar for non-Hodgkin's lymphoma; IBI-302, a bispecific antibody fusion protein for ocular fundus disease; IBI-306, a human monoclonal antibody to treat hypercholesterolemia; IBI-310, a recombinant human anti CTLA-4 monoclonal antibody for liver cancer and renal cell carcinoma. Further the company develops IBI-188, an anti-CD47 monoclonal antibody for advanced hematological and solid tumors; IBI-326, a fully human BCMA-CAR T-cell therapy for the treatment of adults with relapsed or refractory multiple myeloma; IBI-376 for the treatment of recurrent or refractory follicular lymphoma; and IBI-112 for the treatment of psoriasis. Additionally, it distributes pharmaceutical products; and provides consultation, and research and development services. The company has strategic collaborations with NeoCura Bio-Medical Technology Co. Ltd.; Roche Group; Ascentage Pharma Group International; Eli Lilly and Company; Roche Group; and Bolt Biotherapeutics, Inc. Innovent Biologics, Inc. was incorporated in 2011 and is headquartered in Suzhou, the People's Republic of China.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.